Department of Surgery and Transplantation, University Hospital Zürich, Raemistrasse 100, CH-8091, Zürich, Switzerland.
Department of Pathology, University Hospital Zürich, CH-8091, Zürich, Switzerland.
Int J Colorectal Dis. 2020 Apr;35(4):755-758. doi: 10.1007/s00384-020-03514-0. Epub 2020 Jan 25.
In patients with low rectal cancer, the intraoperative assessment of sufficient distal resection margins can be challenging. The assessment determines whether reconstruction can be performed or whether permanent colostomy is required. The goal of the present study was to evaluate intraoperative assessment of the total mesorectal excision (TME) specimen during an interruption of the operation.
The intraoperative strategy of eight patients with low rectal cancer was evaluated. In all cases, intraoperative pathological assessment of the TME specimen by an expert pathologist together with the surgeon was performed. Assessment of the distance of the tumor to the resection margin was measured macroscopically as well as microscopically.
All patients underwent neoadjuvant chemoradiation. The tumor was located at an average 4.8 ± 1.4 cm from the anal verge. In all cases, preoperative MRI revealed mrT3 tumors. The intraoperative assessment showed a median distal resection margin of 10 mm (2-15 mm). In six patients, sufficient margins allowed for reconstruction while in two patients APR was needed. In three patients (37.5%), the pathological assessment changed the operative strategy: In one patient APR could be avoided while two patients required APR instead of the anticipated TME.
The intraoperative assessment of the TME specimen by an expert pathologist together with the surgeon is a valuable tool to avoid unnecessary APR or R1 resections. We therefore suggest routine intraoperative pathological assessment in all operations for borderline low rectal cancers.
在低位直肠癌患者中,充分评估远端切缘具有一定挑战性。这一评估决定了是否能够进行重建,或者是否需要永久性结肠造口术。本研究的目的是评估在手术过程中中断时对全直肠系膜切除术(TME)标本的术中评估。
评估了 8 例低位直肠癌患者的术中策略。在所有情况下,均由专家病理学家与外科医生一起对 TME 标本进行术中病理评估。通过肉眼和显微镜评估肿瘤与切缘的距离。
所有患者均接受新辅助放化疗。肿瘤距肛门边缘平均 4.8±1.4cm。所有病例术前 MRI 显示 mrT3 肿瘤。术中评估显示远端切缘中位数为 10mm(2-15mm)。在 6 例患者中,足够的切缘允许重建,而在 2 例患者中需要行腹会阴联合切除术(APR)。在 3 例患者(37.5%)中,病理评估改变了手术策略:1 例患者可避免 APR,而另外 2 例患者需要 APR 而非预期的 TME。
专家病理学家与外科医生共同对 TME 标本进行术中评估是避免不必要的 APR 或 R1 切除的有效工具。因此,我们建议对所有边界低位直肠癌手术进行常规术中病理评估。